Eli Lilly invites you to explore a new era in the diagnosis and management of Alzheimer's disease (AD), with a special focus on Lormalzi (donanemab). Join leading experts, neurologists Dr. Anshu Rohatgi, Dr. Charulata Sankhla, and Dr. Rajashekar Reddi, along with histopathologist Dr.
Arjun Dang, for a clinically focused discussion on blood biomarkers in AD diagnostics, the clinical outcomes of Lormalzi, and its safety profile, including considerations for ARIA management. The session will conclude with an interactive panel discussion and Q&A, offering participants the opportunity to engage directly with the faculty. Join the experts on July 17 , 2026 , at 8:00 PM IST to gain clinically relevant insights into emerging diagnostic approaches and evolving treatment strategies in Alzheimer's disease. Your participation will help make the discussion even more engaging and meaningful. Agenda :…
